Azenta Inc (AZTA) - Financial and Strategic SWOT Analysis Review

Azenta Inc (AZTA) - Financial and Strategic SWOT Analysis Review


Azenta Inc (AZTA) - Financial and Strategic SWOT Analysis Review


- provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:
  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
  • Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

Azenta Inc (Azenta), formerly Brooks Automation Inc, provides sample exploration and management solutions for the life sciences industry. The company’s product portfolio includes automated storage systems, vaccine cold storage and transport, genomic services, and sample management solutions. It also offers services supporting customers at every stage of the life cycle of samples including procurement and a multitude of sample consumables, informatics and data software, along with sample repository services. Azenta's offerings find application in pharmaceutical, biotechnology, and life sciences research institutions. The company operates through manufacturing facilities in Missouri, the US; Manchester, the UK; and Hosingen, Luxembourg. Azenta is headquartered in Burlington, Massachusetts, the US.

Azenta Inc Key Recent Developments

Nov 12,2024: Azenta Reports Fourth Quarter and Full Year Fiscal 2024 Results; Announces the Plan to Sell B Medical Systems and Appoints Lawrence Y. Lin as CFO
Nov 04,2024: Azenta Announces Appointment of New Independent Directors to Board
Sep 04,2024: Azenta Announces Addition of John Marotta as CEO
Sep 04,2024: Azenta Appoints John Marotta as CEO

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note:Some sections may be missing if data is unavailable for the company


Section 1 - About the Company
Azenta Inc - Key Facts
Azenta Inc - Key Employees
Azenta Inc - Key Employee Biographies
Azenta Inc - Major Products and Services
Azenta Inc - History
Azenta Inc - Company Statement
Azenta Inc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Azenta Inc - Business Description
Business Segment: Life Sciences Products
Overview
Performance
Business Segment: Life Sciences Services
Overview
Performance
Geographical Segment: Africa
Performance
Geographical Segment: Asia/Pacific/Other
Performance
Geographical Segment: China
Performance
Geographical Segment: North America
Performance
Geographical Segment: Rest of Europe
Performance
Geographical Segment: United Kingdom
Performance
R&D Overview
Azenta Inc - Corporate Strategy
Azenta Inc - SWOT Analysis
SWOT Analysis - Overview
Azenta Inc - Strengths
Azenta Inc - Weaknesses
Azenta Inc - Opportunities
Azenta Inc - Threats
Azenta Inc - Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Azenta Inc, Pharmaceuticals & Healthcare, Deals By Year, 2018 to YTD 2024
Azenta Inc, Pharmaceuticals & Healthcare, Deals By Type, 2018 to YTD 2024
Azenta Inc, Recent Deals Summary
Section 5 – Company’s Recent Developments
Nov 12, 2024: Azenta Reports Fourth Quarter and Full Year Fiscal 2024 Results; Announces the Plan to Sell B Medical Systems and Appoints Lawrence Y. Lin as CFO
Nov 04, 2024: Azenta Announces Appointment of New Independent Directors to Board
Sep 04, 2024: Azenta Announces Addition of John Marotta as CEO
Sep 04, 2024: Azenta Appoints John Marotta as CEO
Jul 24, 2024: Brooks Automation to Showcase Innovative Hybrid Lab Automation Solutions at the Association for Diagnostics and Laboratory Medicine Conference (ADLM) July 30-August 1 in Chicago
Jul 24, 2024: Azenta Announces Fiscal 2024 Third Quarter Earnings Conference Call and Webcast
Jul 22, 2024: FinnGen Selects Azenta to Propel Personalized Medicine for Population Health Study
Jun 04, 2024: Azenta Announces Collaboration with the Crohn's & Colitis Foundation to Support its Crohn's Disease and Ulcerative Colitis Clinical Research
May 14, 2024: Azenta deepens UK reach with opening of Oxford genomic lab
May 09, 2024: Azenta Reports Second Quarter Results for Fiscal 2024, Ended March 31, 2024
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer
List of Tables
Azenta Inc, Key Facts
Azenta Inc, Key Employees
Azenta Inc, Key Employee Biographies
Azenta Inc, Major Products and Services
Azenta Inc, History
Azenta Inc, Other Locations
Azenta Inc, Subsidiaries
Azenta Inc, Key Competitors
Azenta Inc, Ratios based on current share price
Azenta Inc, Annual Ratios
Azenta Inc, Annual Ratios (Cont...1)
Azenta Inc, Annual Ratios (Cont...2)
Azenta Inc, Interim Ratios
Azenta Inc, Pharmaceuticals & Healthcare, Deals By Year, 2018 to YTD 2024
Azenta Inc, Pharmaceuticals & Healthcare, Deals By Type, 2018 to YTD 2024
Azenta Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios
List of Figures
Azenta Inc, Performance Chart (2020 - 2024)
Azenta Inc, Ratio Charts
Azenta Inc, Pharmaceuticals & Healthcare, Deals By Year, 2018 to YTD 2024
Azenta Inc, Pharmaceuticals & Healthcare, Deals by Type, 2018 to YTD 2024

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings